Quintiles Draws Curtain On Phase I India Unit As External Business Environment Gets Challenging
This article was originally published in PharmAsia News
Executive Summary
The leading CRO shutters its Phase I unit in Hyderabad inaugurated only two years ago. The decision signifies the tough regulatory challenges global companies are facing in India.